Page last updated: 2024-12-07
s 9977
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
S 9977: may alleviate migranes; RN given refers to hydrochloride; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 132156 |
| SCHEMBL ID | 3247849 |
| MeSH ID | M0204144 |
Synonyms (13)
| Synonym |
|---|
| s 9977 |
| 1,3,7-trimethyl-8-(3-(4-diethylaminocarbonyl-1-piperazinyl)propyl)-3,7-dihydro-(1h)2,6-purinedione |
| s-9977 |
| 138472-18-1 |
| s 9977-2 |
| 1-piperazinecarboxamide, n,n-diethyl-4-(3-(2,3,6,7-tetrahydro-1,3,7-trimethyl-2,6-dioxo-1h-purin-8-yl)propyl)-, monohydrochloride |
| s-9977-2 |
| s9977 , |
| n,n-diethyl-4-(3-(2,3,6,7-tetrahydro-1,3,7-trimethyl-2,6-dioxo-1h-purin-8-yl)propyl)-1-piperazinecarboxamide monohydrochloride |
| SCHEMBL3247849 |
| DTXSID50160688 |
| n,n-diethyl-4-(3-(1,3,7-trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1h-purin-8-yl)propyl)piperazine-1-carboxamide hydrochloride |
| n,n-diethyl-4-[3-(1,3,7-trimethyl-2,6-dioxopurin-8-yl)propyl]piperazine-1-carboxamide;hydrochloride |
Research Excerpts
Overview
S 9977-2 is a new trimethylxanthine derivative with promnesic properties.
| Excerpt | Reference | Relevance |
|---|---|---|
| "S 9977-2 is a new trimethylxanthine derivative with promnesic properties. " | ( Effects of the acute administration of a new trimethylxanthine derivative, S 9977-2, on local cerebral blood flow and glucose utilization in the rat. Boyet, S; Dumont, I; Mocaër, E; Nehlig, A; Schroeder, H, 1992) | 1.96 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (4)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.66
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.66) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||